Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples